Edwards Lifesciences Corporation (EW) Income Statement

	FY25	FY24	FY23	FY22	FY21	FY20	YoY
Revenue
Total Income / Revenue	$6.1B	$5.4B	$5.0B	$4.5B	$5.2B	$4.4B	+11.5%
Cost of Sales	$1.3B	$1.1B	$978.4M	$723.7M	$1.2B	$1.1B	+19.4%
Gross Profit	$4.7B	$4.3B	$4.0B	$3.7B	$4.0B	$3.3B	+9.5%
Expenses
Depreciation & Amortisation	$156.6M	$155.2M	$144.9M	$139.6M	$134.8M	$107.2M	+0.9%
Profit
Operating Profit	$1.3B	$1.4B	$1.3B	$1.5B	$1.7B	$897.6M	-8.3%
Profit Before Tax	$1.3B	$1.5B	$1.4B	$1.5B	$1.7B	$916.7M	-17.8%
Tax Expense	$216.9M	$152.1M	$152.4M	$195.5M	$198.9M	$93.3M	+42.6%
Profit After Tax	$1.1B	$4.2B	$1.4B	$1.5B	$1.5B	—	-74.4%
Attributable to Shareholders	$1.1B	$4.2B	$1.4B	$1.5B	$1.5B	—	-74.3%
Minority Interests	-$4.1M	-$4.9M	-$3.0M	$0	$0	—	+16.3%
Total Comprehensive Income	$1.1B	$4.2B	$1.4B	$1.4B	$1.5B	$818.3M	-74.2%
Basic EPS	$1.84	$6.98	$2.31	$2.46	$2.41	$1.32	-73.6%
Diluted EPS	$1.83	$6.97	$2.30	$2.44	$2.38	$1.30	-73.7%

New to Ticker

Create a free Ticker account to see every line of the income statement, balance sheet and cash flow, plus dividends and financial health.

Edwards Lifesciences Corporation — Income Statement